曾于美国多家生物技术公司任职 “合成致死”疗法瞄准抗癌前沿 南京英派药业创始人蔡遂雄：优化管线布局

特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。

Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.